Compositions and methods for treatment of pre-cancerous skin lesions
The present disclosure encompasses compositions and methods for the treatment of precancerous skin lesions. Compositions of the invention comprise a cytotoxic agent and a thymic stromal lymphopoietin (TSLP) inducer.
1. A method to treat a squamous cell carcinoma, the method comprising topically administering to the squamous cell carcinoma a composition comprising a cytotoxic agent and a thymic stromal lymphopoietin (TSLP) inducer.
2. The method of claim 1 , wherein the TSLP inducer is calcipotriol.
3. The method of claim 1 , wherein the cytotoxic agent is 5-fluorouracil (5-FU).
4. The method of claim 3 , wherein the composition comprises about 2% to about 5% 5-FU.
5. The method of claim 2 , wherein the composition comprises about 0.002% to about 0.005% calcipotriol.
6. The method of claim 1 , wherein the squamous cell carcinoma is squamous cell carcinoma in situ (SCCIS).
7. The method of claim 1 , wherein the composition is administered twice a day for 4 to 6 days.
8. The method of claim 1 , wherein the squamous cell carcinoma is reduced in size by 50% or greater.